ArticleChest2026
The Impact of Weight Loss on the Physiological Endotypes Associated With OSA.
Article in Chest, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Reply to "From coexistence to causation: defining adiposity-attributable obstructive sleep apnea".Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2026Article
- GLP-1 Receptor Agonists in Obstructive Sleep Apnea: A Translational Perspective on Mechanisms and Clinical Implications.International journal of molecular sciences · 2026Review
- Incretin-Based Therapies in Obesity-Related Obstructive Sleep Apnea: A Narrative Review of Evidence Tiers and Mechanistic Plausibility.Nature and science of sleep · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
backgroundWeight loss improves upper airway collapsibility in people with OSA. However, it is unclear how weight loss affects the other physiological traits (ie, endotypes) associated with OSA (loop gain, arousal threshold, and muscle compensation). RESEARCH QUESTIONS: What is the effect of metabolic bariatric surgery on the OSA endotypes, and are the baseline endotypes associated with improvements in OSA severity? STUDY DESIGN AND
methodsUsing noninvasive methods, the OSA endotypes were measured during overnight clinical polysomnography in 43 patients before and after (approximately 6-18 months) metabolic bariatric surgery. OSA endotypes were also measured, using reference standard physiological techniques (ie, CPAP dial-down method) in a subset of patients (n = 10). Generalized linear mixed-effects models were used to evaluate the effect on outcome variables.
resultsMetabolic bariatric surgery was associated with improvements in apnea-hypopnea index (AHI; 50.7 ± 26.8 vs 24.6 ± 19.2 events/h; P < .001), BMI (42.1 ± 5.5 vs 32.8 ± 4.5 kg/m
interpretationOur results show that metabolic bariatric surgery is associated with improvements in weight, AHI, upper airway collapsibility, and loop gain and may be particularly effective for those with mild upper airway collapsibility and low loop gain.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.